Oncogenesis, lipids rafts and liquid crystals: A nanoscopic supplementary field for applied researches and a new hope of advances in cancer

肿瘤发生、脂筏和液晶:纳米尺度下的应用研究补充领域,以及癌症治疗取得进展的新希望

阅读:1

Abstract

Liquid crystals (LC) are an intermediate state between an ordered crystalline solid and a more disordered liquid. LCs (or mesophases) are ubiquitous in living systems, optimizing multiple biological functions that could not operate in purely solid or liquid environments as both mobility and organization are needed. One of us recently suggested that there is an information vector, shared by neurodegenerative and infectious pathologies, to be found within lipid rafts in an ordered liquid (Lo) form mediated by cholesterol. Here we extend this underlying mechanism to oncogenic processes. The specificity of our approach lies in highlighting the direct involvement of liquid crystals in early carcinogenic processes, by identifying specific metabolic pathways, with the intention of focusing research effort on this level, now that this has become technically feasible. Exploring LCs in living bodies reveals links between numerous oncogenic mechanisms. The approach is based on the geometric properties of amphiphilic (hydrophilic and lipophilic) plasma and intracellular membranes, the phospholipids of which are an example of the lamellar LC phase. These LCs underlie cell signaling and signaling pathways disorders at membrane level: consequently, they are directly concerned with deregulation underlying many cancerous processes. We demonstrate the implication of cancer cell membranes mesophases. That is in the membranes mesophases that are initiated most of metabolic pathways, leading to downstream pathogenic intracellular mechanisms. The concepts of order and of symmetry, in the mathematical sense, involved in condensed matter accompany informed adaptive supramolecular chemical processes in forming self-organizing mesogenic molecular assemblies. Multidisciplinary teamwork combining knowledge from different fields holds out the hope of therapeutic progress upstream of irreversible cancerous processes, while conserving the physiological integrity of the cells themselves.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。